Cargando…

Biochemical Markers in Alzheimer’s Disease

Alzheimer’s disease (AD) is one of the most frequent neurodegenerative diseases affecting more than 35 million people in the world, and its incidence is estimated to triple by 2050. Alzheimer’s disease is an age-related disease characterized by the progressive loss of memory and cognitive function,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabbito, Alessandro, Dulewicz, Maciej, Kulczyńska-Przybik, Agnieszka, Mroczko, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139967/ https://www.ncbi.nlm.nih.gov/pubmed/32183332 http://dx.doi.org/10.3390/ijms21061989

Ejemplares similares

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Dulewicz, Maciej, et al.
Publicado: (2020)

The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2021)

Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2023)

The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2021)

The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2023)

Biomarkers of Activity-Dependent Plasticity and Persistent Enhancement of Synaptic Transmission in Alzheimer Disease: A Review of the Current Status
por: Warpechowski, Marcin, et al.
Publicado: (2023)

Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2022)

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
por: Zajkowska, Monika, et al.
Publicado: (2022)

Eotaxins and Their Receptor as Biomarkers of Colorectal Cancer
por: Zajkowska, Monika, et al.
Publicado: (2021)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease
por: Muszyński, Paweł, et al.
Publicado: (2017)

The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review
por: Kulikowska, Joanna, et al.
Publicado: (2021)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2022)

Amyloid and Tau Protein Concentrations in Children with Meningitis and Encephalitis
por: Sulik, Artur, et al.
Publicado: (2022)

The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2020)

CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression
por: Pączek, Sara, et al.
Publicado: (2020)

Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer
por: Pawluczuk, Elżbieta, et al.
Publicado: (2021)

Investigating the Role of Serum and Plasma IL-6, IL-8, IL-10, TNF-alpha, CRP, and S100B Concentrations in Obstructive Sleep Apnea Diagnosis
por: Fiedorczuk, Piotr, et al.
Publicado: (2023)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

Optimized RT-qPCR and a novel normalization method for validating circulating miRNA biomarkers in ageing-related diseases
por: Want, Andrew, et al.
Publicado: (2023)

Biochemical Markers of Colorectal Cancer – Present and Future
por: Jelski, Wojciech, et al.
Publicado: (2020)

The Significance of CXCL1 and CXCR1 as Potential Biomarkers of Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2023)

Alzheimer’s Disease—Biochemical and Psychological Background for Diagnosis and Treatment
por: Beata, Bocwinska-Kiluk, et al.
Publicado: (2023)

Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
por: Doroszkiewicz, Julia, et al.
Publicado: (2023)

New Possibilities in the Therapeutic Approach to Alzheimer’s Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2022)

Molecular Aspects of a Diet as a New Pathway in the Prevention and Treatment of Alzheimer’s Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2023)

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)
por: Mroczko, Barbara, et al.
Publicado: (2019)

Some Biochemical Markers in Patients with Alzheimer’s Disease
por: KHANAHMADI, Mohammad, et al.
Publicado: (2016)

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
por: Mroczko, Barbara, et al.
Publicado: (2018)

Clinical significance of fluid biomarkers in Alzheimer’s Disease
por: Lewczuk, Piotr, et al.
Publicado: (2020)

The biochemical study on the etiology of Alzheimer’s disease
por: Imahori, Kazutomo
Publicado: (2010)

Tetramodal Chemical Imaging Delineates the Lipid–Amyloid Peptide Interplay at Single Plaques in Transgenic Alzheimer’s Disease Models
por: Ge, Junyue, et al.
Publicado: (2023)

Liraglutide and its Neuroprotective Properties—Focus on Possible Biochemical Mechanisms in Alzheimer’s Disease and Cerebral Ischemic Events
por: Wiciński, Michał, et al.
Publicado: (2019)

The Usefulness of Biological and Neuroimaging Markers for the Diagnosis of Early-Onset Alzheimer's Disease
por: Padovani, Alessandro, et al.
Publicado: (2011)

Biochemical markers for cancer
por: Cooper, E.H.
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_h8uf7fiiopaoa801tg6fr935mo